MVA-MUC1-IL2 Vaccine

Definition 1

A bivalent cancer vaccine comprised of a modified vaccinia virus Ankara (MVA) strain encoding human mucin 1 (MUC1) and interleukin-2 (IL-2) with potential immunostimulating and antineoplastic activities. Originally developed for the eradication of smallpox, MVA is a highly attenuated and replication-defective strain incapable of virion assembly and exerts potent immunostimulatory activity against antigens. Vaccination with MVA-MUC1-IL2 vaccine may stimulate the host immune system to mount a humoral and cytotoxic T lymphocyte (CTL) responses against tumor cells expressing MUC1, a tumor associated antigen, resulting in tumor cell lysis. Expression of IL-2 augments the specific CTL response against MUC1 expressing cells. (NCI Thesaurus)

Definition 2

A substance that is being studied as an anticancer drug. (NCI Dictionary)

YOU MAY ALSO LIKE

MVA-FCU1 TG4023

A cancer vaccine comprised of a recombinant modified vaccinia Ankara (MVA) viral vector encoding the suicide gene FCU1 with potential antineoplastic…

MVA-EBNA1/LMP2 Vaccine

A cancer vaccine consisting of a recombinant modified vaccinia Ankara (MVA) viral vector encoding the gene for the CD4 epitope-rich C-terminal domain…

MUTYH-Associate Polyposis

An autosomal recessive hereditary neoplastic syndrome caused by mutations in the MUTYH gene on chromosome 1p34.1. It is characterized by the…

MUTYH wt Allele

Human MUTYH allele is located within 1p34.3-p32.1 and is approximately 92 kb in length. This allele, which encodes A/G-specific adenine DNA glycosylase…

MUTYH Gene Mutation

A molecular genetic abnormality that refers to the mutation of the MUTYH gene on chromosome 1p34.1.

MUTYH Gene

This gene plays a role in the repair of oxidative DNA damage.